Tech Company Financing Transactions
LumaBridge Funding Round
LumaBridge, based in San Antonio, secured investment capital from Summit Partners.
Transaction Overview
Company Name
Announced On
8/23/2022
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Summit Partners (Lead Investor) (Mark deLaar)
Proceeds Purpose
The funding will help the company continue to build on its work offering clinical trial solutions to support emerging biopharma companies that are working to develop life-changing immuno-oncology treatments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1305 East Houston St
San Antonio, TX 78205
USA
San Antonio, TX 78205
USA
Phone
Undisclosed
Website
Email Address
Overview
LumaBridge is an oncology-focused CRO, designing and executing innovative clinical trial solutions for emerging biopharma companies. Create a culture of high-performing teams in partnership with our stakeholders to advance the development of promising medical therapies and technologies for the benefit of patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Boyle
Chief Financial Officer
Steven White
Chief Operating Officer
Lori McDermott
President
Daniel Hargrove
Browse more venture capital transactions:
Prev: 8/23/2022: Mojocare venture capital transaction
Next: 8/23/2022: Celonis venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs